仙乐健康: 关于仙乐转债暂停转股的提示性公告

Core Points - The company, Xianle Health Technology Co., Ltd., will soon announce the implementation of the 2024 equity distribution, which will affect the convertible bonds [1] - The convertible bonds (code: 123113; abbreviation: Xianle Convertible Bonds) will suspend conversion from May 13, 2025, until the equity registration date for the 2024 distribution, resuming on the first trading day after the registration [1] - The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] Summary by Sections - Convertible Bond Adjustment: The adjustment of the conversion price for the convertible bonds will occur in the event of stock dividends, capital increases, new share issuances, rights issues, or cash dividends, with specific formulas provided for each scenario [1][2] - Price Adjustment Mechanism: The formulas for adjusting the conversion price are detailed, including variables such as the previous conversion price (P0), stock dividend rate (n), new share issuance rate (k), new share price (A), and cash dividend per share (D) [1][2] - Disclosure of Adjustments: The company will publish announcements regarding the adjustment of the conversion price in designated media, including the adjustment date, method, and any suspension of conversion [2]